Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Prif Awdur: | Tamanna, Mst. Taskia |
---|---|
Awduron Eraill: | Sharmin, Dr. Sabrina |
Fformat: | Traethawd Ymchwil |
Iaith: | English |
Cyhoeddwyd: |
Brac University
2023
|
Pynciau: | |
Mynediad Ar-lein: | http://hdl.handle.net/10361/18146 |
Eitemau Tebyg
-
Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
gan: Hassan, Md. Muhtaz
Cyhoeddwyd: (2020) -
Role of protein’s and future treatment options for Alzheimer’s Disease
gan: Islam, Md. Irfath
Cyhoeddwyd: (2023) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
gan: Alim, Abdul
Cyhoeddwyd: (2023) -
Marine compounds in the treatment of Alzheimer’s disease
gan: Parveen, Sanjana
Cyhoeddwyd: (2022) -
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
gan: Tabassum, Nadira
Cyhoeddwyd: (2024)